The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 491 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 3,084 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| ALKERMES PLC | SHS | G01767105 | 3,084 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 1,020 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| AMRYT PHARMA PLC | SPONSORED ADS | 03217L106 | 3,023 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 1,820 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 3,003 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 2,959 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 2,230 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| DURECT CORP | COM | 266605104 | 320 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 392 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 4,191 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 3,821 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| GREENLANE HLDGS INC | CL A | 395330103 | 830 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 2,612 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | 3,004 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| PFIZER INC | COM | 717081103 | 3,226 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| PFIZER INC | COM | 717081103 | 2,151 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| PROSHARES TR | ULTRAPRO SHORT S | 74347B110 | 2,631 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| PROSHARES TR | ULTRAPRO SHT QQQ | 74347G861 | 1,726 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| PROSHARES TR II | VIX SH TRM FUTRS | 74347Y854 | 285 | 12,500 | SH | Call | SOLE | 12,500 | 0 | 0 | |
| PROSHARES TR II | ULTRA VIX SHORT | 74347Y839 | 1,228 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| TYME TECHNOLOGIES INC | COM | 90238J103 | 2,060 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 907 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| VYNE THERAPEUTICS INC | COM | 92941V209 | 556 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||